Poly(2-ethyl-2-oxazoline)-PLA-g-PEI amphiphilic triblock micelles for co-delivery of minicircle DNA and chemotherapeutics

Journal of Controlled Release

Volumn 189, Issue , 2014, Pages 90-104

  Gaspar, Vítor M ^a   Gonçalves, Cristine ^b   De Melo Diogo, Duarte ^a   Costa, Elisabete C ^a   Queiroz, João A ^a   Pichon, Chantal ^b   Sousa, Fani ^a   Correia, Ilídio J ^a  

^a UNIVERSITY OF BEIRA INTERIOR   (Portugal)

^b UNIVERSITÉ D'ORLÉANS   (France)

Author keywords

Anti tumoral drugs; Cancer therapy; Co delivery; Micellar carriers; Minicircle DNA

Indexed keywords

BIOCOMPATIBILITY; DNA; GENE EXPRESSION; MICELLES; POLYETHYLENE GLYCOLS; POLYETHYLENE OXIDES; TARGETED DRUG DELIVERY;

ANTI-TUMORAL ACTIVITY; ANTI-TUMORAL DRUGS; CANCER THERAPY; CO DELIVERIES; CRITICAL MICELLAR CONCENTRATIONS; FUNCTIONALIZATIONS; MULTICELLULAR SPHEROID; POLY(2-ETHYL-2-OXAZOLINE);

CONTROLLED DRUG DELIVERY;

AMPHOPHILE; COPOLYMER; DOXORUBICIN; MINICIRCLE DNA; NANOCARRIER; POLY(2 ETHYL 2 OXAZOLINE); UNCLASSIFIED DRUG; ANTINEOPLASTIC ANTIBIOTIC; CIRCULAR DNA; DRUG CARRIER; GREEN FLUORESCENT PROTEIN; LACTIC ACID; MICELLE; POLY(2-ETHYL-2-OXAZOLINE); POLYAMINE; POLYETHYLENEIMINE; POLYLACTIC ACID; POLYMER;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOCOMPATIBILITY; CONTROLLED STUDY; CRITICAL MICELLE CONCENTRATION; DRUG DELIVERY SYSTEM; DRUG STABILITY; DRUG UPTAKE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HYDROPHILICITY; MCF 7 CELL LINE; MULTICELLULAR SPHEROID; NANOENCAPSULATION; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RAT; TUMOR SPHEROID; ANIMAL; BAGG ALBINO MOUSE; BREAST NEOPLASMS; CHEMISTRY; DRUG EFFECTS; ERYTHROCYTE; FIBROBLAST; GENETICS; HEMOLYSIS; METABOLISM; MICELLE; TUMOR CELL LINE; WISTAR RAT;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BREAST NEOPLASMS; CELL LINE, TUMOR; DNA, CIRCULAR; DOXORUBICIN; DRUG CARRIERS; ERYTHROCYTES; FEMALE; FIBROBLASTS; GREEN FLUORESCENT PROTEINS; HEMOLYSIS; HUMANS; LACTIC ACID; MCF-7 CELLS; MICE, INBRED BALB C; MICELLES; POLYAMINES; POLYETHYLENEIMINE; POLYMERS; RATS, WISTAR; SPHEROIDS, CELLULAR;

EID: 84904182939     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2014.06.040     Document Type: Article

References (57)

1. V.M. Gaspar, I.J. Correia, Â. Sousa, F. Silva, C.M. Paquete, J.A. Queiroz, and F. Sousa Nanoparticle mediated delivery of pure P53 supercoiled plasmid DNA for gene therapy J. Control. Release 156 2011 212 222
2. M. Brenner, and M.-C. Hung Cancer Gene Therapy by Viral and Non-viral Vectors 2014 John Wiley & Sons
3. M.A. Kay State-of-the-art gene-based therapies: the road ahead Nat. Rev. Genet. 12 2011 316 328
4. L.E.G. Maniar, J.M. Maniar, Z.-Y. Chen, J. Lu, A.Z. Fire, and M.A. Kay Minicircle DNA vectors achieve sustained expression reflected by active chromatin and transcriptional level Mol. Ther. 21 2013 131 138
5. J. Mairhofer, and R. Grabherr Rational vector design for efficient non-viral gene delivery: challenges facing the use of plasmid DNA Mol. Biotechnol. 39 2008 97 104
6. M. Grund, and M. Schleef Minicircle Patents: A Short IP Overview of Optimizing Nonviral DNA Vectors, Minicircle and Miniplasmid DNA Vectors: The Future of Nonviral and Viral Gene Transfer 2013 1 6
7. A. Darquet, B. Cameron, P. Wils, D. Scherman, and J. Crouzet A new DNA vehicle for nonviral gene delivery: supercoiled minicircle Gene Ther. 4 1997 1341
8. M.A. Kay, C.Y. He, and Z.Y. Chen A robust system for production of minicircle DNA vectors Nat. Biotechnol. 28 2010 1287 1289
9. V.M. Gaspar, C.J. Maia, J.A. Queiroz, C. Pichon, I.J. Correia, and F. Sousa Improved minicircle DNA biosynthesis for gene therapy applications Hum. Gene Ther. Methods 25 2014 93 105
10. H.M. Viecelli, R.P. Harbottle, S.P. Wong, A. Schlegel, M.K. Chuah, T. VandenDriessche, C.O. Harding, and B. Thöny Treatment of phenylketonuria using minicircle based naked DNA gene transfer to murine liver Hepatology 2014 (in press)
11. D. Catanese, J. Fogg, D. Schrock, B. Gilbert, and L. Zechiedrich Supercoiled minivector DNA resists shear forces associated with gene therapy delivery Gene Ther. 19 2011 94 100
12. M. Wang, K. Alberti, S. Sun, C.L. Arellano, and Q. Xu Combinatorially designed lipid-like nanoparticles for intracellular delivery of cytotoxic protein for cancer therapy Angew. Chem. 126 2014 2937 2942
13. J. Li, Y. Wang, Y. Zhu, and D. Oupický Recent advances in delivery of drug-nucleic acid combinations for cancer treatment J. Control. Release 172 2013 589 600
14. H. Fan, Q.-D. Hu, F.-J. Xu, W.-Q. Liang, G.-P. Tang, and W.-T. Yang In vivo treatment of tumors using host-guest conjugated nanoparticles functionalized with doxorubicin and therapeutic gene pTRAIL Biomaterials 33 2012 1428 1436
15. L.K. Bogart, G. Pourroy, C.J. Murphy, V. Puntes, T. Pellegrino, D. Rosenblum, D. Peer, and R. Lévy Nanoparticles for imaging, sensing, and therapeutic intervention ACS Nano 8 2014 3107 3122
16. M. Keeney, S.-G. Ong, A. Padilla, Z. Yao, S. Goodman, J.C. Wu, and F. Yang Development of poly(β-amino ester)-based biodegradable nanoparticles for nonviral delivery of minicircle DNA ACS Nano 7 2013 7241 7250
17. M.J. Osborn, R.T. McElmurry, C.J. Lees, A.P. DeFeo, Z.-Y. Chen, M.A. Kay, L. Naldini, G. Freeman, J. Tolar, and B.R. Blazar Minicircle DNA-based gene therapy coupled with immune modulation permits long-term expression of [alpha]-L-Iduronidase in mice with mucopolysaccharidosis type I Mol. Ther. 19 2011 450 460
18. O. Taratula, A. Kuzmov, M. Shah, O.B. Garbuzenko, and T. Minko Nanostructured lipid carriers as multifunctional nanomedicine platform for pulmonary co-delivery of anticancer drugs and siRNA J. Control. Release 171 2013 349 357
19. W.X. Mai, T. Xia, and H. Meng Development of pharmaceutically adapted mesoporous silica nanoparticles for siRNA delivery Advanced Delivery and Therapeutic Applications of RNAi 2013 187 205
20. L. Zhu, F. Perche, T. Wang, and V.P. Torchilin Matrix metalloproteinase 2-sensitive multifunctional polymeric micelles for tumor-specific co-delivery of siRNA and hydrophobic drugs Biomaterials 35 2014 4213 4222
21. C. Liu, F. Liu, L. Feng, M. Li, J. Zhang, and N. Zhang The targeted co-delivery of DNA and doxorubicin to tumor cells via multifunctional PEI-PEG based nanoparticles Biomaterials 34 2013 2547 2564
22. M. Lundqvist Nanoparticles: tracking protein corona over time Nat. Nanotechnol. 8 2013 701 702
23. R.I. El-Gogary, N. Rubio Carrero, J.T.-W. Wang, W.T. Al-Jamal, M. Bourgognon, H. Kafa, M. Naeem, R. Klippstein, V. Abbate, and F. Leroux Polyethylene glycol conjugated polymeric nanocapsules for targeted delivery of quercetin to folate-expressing cancer cells in vitro and in vivo ACS Nano 8 2014 1384 1401
24. N. Kamaly, Z. Xiao, P.M. Valencia, A.F. Radovic-Moreno, and O.C. Farokhzad Targeted polymeric therapeutic nanoparticles: design, development and clinical translation Chem. Soc. Rev. 41 2012 2971 3010
25. T. Ishida, X. Wang, T. Shimizu, K. Nawata, and H. Kiwada PEGylated liposomes elicit an anti-PEG IgM response in a T cell-independent manner J. Control. Release 122 2007 349 355 (Pubitemid 47407760)
26. A.S. Abu Lila, H. Kiwada, and T. Ishida The accelerated blood clearance (ABC) phenomenon: clinical challenge and approaches to manage J. Control. Release 172 2013 38 47
27. R. Saadati, S. Dadashzadeh, Z. Abbasian, and H. Soleimanjahi Accelerated blood clearance of pegylated plga nanoparticles following repeated injections: effects of polymer dose, peg coating, and encapsulated anticancer drug Pharm. Res. 30 2013 985 995
28. A. Mero, G. Pasut, L.D. Via, M.W. Fijten, U.S. Schubert, R. Hoogenboom, and F.M. Veronese Synthesis and characterization of poly(2-ethyl 2-oxazoline)-conjugates with proteins and drugs: suitable alternatives to PEG-conjugates? J. Control. Release 125 2008 87 95
29. R. Hoogenboom, and H. Schlaad Bioinspired poly(2-oxazoline) s Polymers 3 2011 467 488
30. R. Luxenhofer, G. Sahay, A. Schulz, D. Alakhova, T.K. Bronich, R. Jordan, and A.V. Kabanov Structure-property relationship in cytotoxicity and cell uptake of poly(2-oxazoline) amphiphiles J. Control. Release 153 2011 73 82
31. T.X. Viegas, M.D. Bentley, J.M. Harris, Z. Fang, K. Yoon, B. Dizman, R. Weimer, A. Mero, G. Pasut, and F.M. Veronese Polyoxazoline: chemistry, properties, and applications in drug delivery Bioconjug. Chem. 22 2011 976 986
32. J. Ulbricht, R. Jordan, and R. Luxenhofer On the biodegradability of polyethylene glycol, polypeptoids and poly(2-oxazoline) s Biomaterials 35 2014 4848 4861
33. L.-Y. Qiu, L. Yan, L. Zhang, Y.-M. Jin, and Q.-H. Zhao Folate-modified poly(2-ethyl-2-oxazoline) as hydrophilic corona in polymeric micelles for enhanced intracellular doxorubicin delivery Int. J. Pharm. 456 2013 315 324
34. J.G. Marques, V.M. Gaspar, D. Markl, E.C. Costa, E. Gallardo, and I.J. Correia Co-delivery of Sildenafil (Viagra®) and Crizotinib for synergistic and improved anti-tumoral therapy Pharm. Res. 2014 1 13
35. J. Aguiar, P. Carpena, J. Molina-BolIvar, and C. Carnero Ruiz On the determination of the critical micelle concentration by the pyrene 1:3 ratio method J. Colloid Interface Sci. 258 2003 116 122 (Pubitemid 36228364)
36. G. Basu Ray, I. Chakraborty, and S.P. Moulik Pyrene absorption can be a convenient method for probing critical micellar concentration (cmc) and indexing micellar polarity J. Colloid Interface Sci. 294 2006 248 254 (Pubitemid 41711688)
37. V. Gaspar, J. Marques, F. Sousa, R. Louro, J. Queiroz, and I. Correia Biofunctionalized nanoparticles with pH-responsive and cell penetrating blocks for gene delivery Nanotechnology 24 2013 275101
38. V.r. Bennevault-Celton, A. Urbach, O. Martin, C. Pichon, P. Guégan, and P. Midoux Supramolecular assemblies of histidinylated α-cyclodextrin in the presence of DNA scaffold during CDplexes formation Bioconjug. Chem. 22 2011 2404 2414
39. I. Horcas, R. Fernández, J.M. Gómez-Rodríguez, J. Colchero, J. Gómez-Herrero, and A.M. Baro WSXM: a software for scanning probe microscopy and a tool for nanotechnology Rev. Sci. Instrum. 78 2007
40. Y. Li, K. Xiao, J. Luo, W. Xiao, J.S. Lee, A.M. Gonik, J. Kato, T.A. Dong, and K.S. Lam Well-defined, reversible disulfide cross-linked micelles for on-demand paclitaxel delivery Biomaterials 32 2011 6633 6645
41. J. Schindelin, I. Arganda-Carreras, E. Frise, V. Kaynig, M. Longair, T. Pietzsch, S. Preibisch, C. Rueden, S. Saalfeld, and B. Schmid Fiji: an open-source platform for biological-image analysis Nat. Methods 9 2012 676 682
42. A.P. Napolitano, D.M. Dean, A.J. Man, J. Youssef, D.N. Ho, A.P. Rago, M.P. Lech, and J.R. Morgan Scaffold-free three-dimensional cell culture utilizing micromolded nonadhesive hydrogels Biotechniques 43 2007 494
43. P. Li, P. Lai, and C. Lin Reversal of multidrug resistance using poly(l-lactide)-Vitamin E TPGS micelles in breast cancer cell Biomedical and Pharmaceutical Engineering, 2009. ICBPE'09. International Conference on 2009 IEEE 1 5
44. V.M. Gaspar, C. Cruz, J.A. Queiroz, C. Pichon, I.J. Correia, and F. Sousa Sensitive detection of peptide-minicircle DNA interactions by surface plasmon resonance Anal. Chem. 85 2013 2304 2311
45. T.K. Endres, M. Beck-Broichsitter, O. Samsonova, T. Renette, and T.H. Kissel Self-assembled biodegradable amphiphilic PEG-PCL-lPEI triblock copolymers at the borderline between micelles and nanoparticles designed for drug and gene delivery Biomaterials 32 2011 7721 7731
46. S. Kulthe, N. Inamdar, Y. Choudhari, S. Shirolikar, L. Borde, and V. Mourya Mixed micelle formation with hydrophobic and hydrophilic Pluronic block copolymers: implications for controlled and targeted drug delivery Colloids Surf. B: Biointerfaces 88 2011 691 696
47. N. Adams, and U.S. Schubert Poly(2-oxazolines) in biological and biomedical application contexts Adv. Drug Deliv. Rev. 59 2007 1504 1520 (Pubitemid 350122776)
48. S. Maya, L.G. Kumar, B. Sarmento, N. Sanoj Rejinold, D. Menon, S.V. Nair, and R. Jayakumar Cetuximab conjugated O-carboxymethyl chitosan nanoparticles for targeting EGFR overexpressing cancer cells Carbohydr. Polym. 93 2013 661 669
49. G. Mehta, A.Y. Hsiao, M. Ingram, G.D. Luker, and S. Takayama Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy J. Control. Release 164 2012 192 204
50. B. Weigelt, and M.J. Bissell The need for complex 3D culture models to unravel novel pathways and identify accurate biomarkers in breast cancer Adv. Drug Deliv. Rev. 69-70 2014 42 51
51. S. Bagai, C. Sun, and T. Tang Potential of mean force of polyethylenimine-mediated DNA attraction J. Phys. Chem. B 117 2012 49 56
52. R. Dias, and B. Lindman DNA Interactions With Polymers and Surfactants 2008 Wiley Online Library
53. C. Cui, Y.-N. Xue, M. Wu, Y. Zhang, P. Yu, L. Liu, R.-X. Zhuo, and S.-W. Huang Cellular uptake, intracellular trafficking, and antitumor efficacy of doxorubicin-loaded reduction-sensitive micelles Biomaterials 34 2013 3858 3869
54. R. Jayakumar, A. Nair, N.S. Rejinold, S. Maya, and S. Nair Doxorubicin-loaded pH-responsive chitin nanogels for drug delivery to cancer cells Carbohydr. Polym. 87 2012 2352 2356
55. W. Gao, B. Xiang, T.-T. Meng, F. Liu, and X.-R. Qi Chemotherapeutic drug delivery to cancer cells using a combination of folate targeting and tumor microenvironment-sensitive polypeptides Biomaterials 34 2013 4137 4149
56. C.F. Thorn, C. Oshiro, S. Marsh, T. Hernandez-Boussard, H. McLeod, T.E. Klein, and R.B. Altman Doxorubicin pathways: pharmacodynamics and adverse effects Pharmacogenet. Genomics 21 2011 440
57. D.Y. Lu, M. Huang, C.H. Xu, W.Y. Yang, C.X. Hu, L.P. Lin, L.J. Tong, M.H. Li, W. Lu, and X.W. Zhang Anti-proliferative effects, cell cycle G2/M phase arrest and blocking of chromosome segregation by probimane and MST-16 in human tumor cell lines BMC Pharmacol. 5 2005 11